Literature DB >> 26770405

Identifying the genes regulated by IDH1 via gene-chip in glioma cell U87.

Jie Ren1, Meiqing Lou2, Jinlong Shi3, Yajun Xue2, Daming Cui1.   

Abstract

Glioma is the most common form of primary brain tumor. Increasing evidence show that IDH1 gene mutation is implicated in glioma. However, the mechanism involved in the progression of glioma remains unclear until now. In the study reported here, we used gene chip to identifying the genes regulated with IDH mutanted at R132. The results showed that IDH1-mutant leads to 1255 up-regulated genes and 1862 down-regulated genes in U87 cell lines. Meanwhile, GO and gene-network was performed and shown IDH1-mutant mainly affect small molecule metabolic process, mitotic cell cycle and apoptosis. This result will lay a foundation for further study of IDH1 gene function in the future.

Entities:  

Keywords:  Glioma; IDH1; gene mutation; gene-chip; overexpression

Year:  2015        PMID: 26770405      PMCID: PMC4694305     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  IDH1 and IDH2 mutations in gliomas.

Authors:  François Ducray; Yannick Marie; Marc Sanson
Journal:  N Engl J Med       Date:  2009-05-21       Impact factor: 91.245

2.  The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase.

Authors:  B V Geisbrecht; S J Gould
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

3.  Analysis of the IDH1 codon 132 mutation in brain tumors.

Authors:  Jörg Balss; Jochen Meyer; Wolf Mueller; Andrey Korshunov; Christian Hartmann; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2008-11-05       Impact factor: 17.088

4.  Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity.

Authors:  Xiang Xu; Jingyue Zhao; Zhen Xu; Baozhen Peng; Qiuhua Huang; Eddy Arnold; Jianping Ding
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

5.  Mammalian Mcm2/4/6/7 complex forms a toroidal structure.

Authors:  Norikazu Yabuta; Naoko Kajimura; Kouta Mayanagi; Michio Sato; Takahito Gotow; Yasuo Uchiyama; Yukio Ishimi; Hiroshi Nojima
Journal:  Genes Cells       Date:  2003-05       Impact factor: 1.891

6.  Recurring mutations found by sequencing an acute myeloid leukemia genome.

Authors:  Elaine R Mardis; Li Ding; David J Dooling; David E Larson; Michael D McLellan; Ken Chen; Daniel C Koboldt; Robert S Fulton; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Devin P Locke; Vincent J Magrini; Rachel M Abbott; Tammi L Vickery; Jerry S Reed; Jody S Robinson; Todd Wylie; Scott M Smith; Lynn Carmichael; James M Eldred; Christopher C Harris; Jason Walker; Joshua B Peck; Feiyu Du; Adam F Dukes; Gabriel E Sanderson; Anthony M Brummett; Eric Clark; Joshua F McMichael; Rick J Meyer; Jonathan K Schindler; Craig S Pohl; John W Wallis; Xiaoqi Shi; Ling Lin; Heather Schmidt; Yuzhu Tang; Carrie Haipek; Madeline E Wiechert; Jolynda V Ivy; Joelle Kalicki; Glendoria Elliott; Rhonda E Ries; Jacqueline E Payton; Peter Westervelt; Michael H Tomasson; Mark A Watson; Jack Baty; Sharon Heath; William D Shannon; Rakesh Nagarajan; Daniel C Link; Matthew J Walter; Timothy A Graubert; John F DiPersio; Richard K Wilson; Timothy J Ley
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245

Review 7.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

8.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.

Authors:  Phillip L Ross; Iona Cheng; Xin Liu; Mine S Cicek; Peter R Carroll; Graham Casey; John S Witte
Journal:  BMC Cancer       Date:  2009-02-26       Impact factor: 4.430

10.  Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays.

Authors:  Hannah C Cheung; Keith A Baggerly; Spiridon Tsavachidis; Linda L Bachinski; Valerie L Neubauer; Tamara J Nixon; Kenneth D Aldape; Gilbert J Cote; Ralf Krahe
Journal:  BMC Genomics       Date:  2008-05-12       Impact factor: 3.969

View more
  2 in total

1.  Downregulation of Brain Enriched Type 2 MAGEs Is Associated With Immune Infiltration and Poor Prognosis in Glioma.

Authors:  Mohit Arora; Sarita Kumari; Jay Singh; Anita Chopra; Shyam S Chauhan
Journal:  Front Oncol       Date:  2020-12-23       Impact factor: 5.738

2.  Long Noncoding RNA miR210HG as a Potential Biomarker for the Diagnosis of Glioma.

Authors:  Weijie Min; Dongwei Dai; Jiaqi Wang; Dandan Zhang; Yuhui Zhang; Guosheng Han; Lei Zhang; Chao Chen; Xiulong Li; Yanan Li; Zhijian Yue
Journal:  PLoS One       Date:  2016-09-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.